Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

FWP

Forward Pharma AS (FWP)

Forward Pharma AS
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FWP
DateHeureSourceTitreSymboleSociété
14/02/202322h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
24/01/202312h08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
13/01/202322h43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
06/01/202315h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FWPForward Pharma AS
19/12/202212h00GlobeNewswire Inc.Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketNASDAQ:FWPForward Pharma AS
06/12/202220h00GlobeNewswire Inc.Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewNASDAQ:FWPForward Pharma AS
08/04/202223h25GlobeNewswire Inc.Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021NASDAQ:FWPForward Pharma AS
13/12/202123h04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FWPForward Pharma AS
13/12/202123h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FWPForward Pharma AS
06/09/202116h21GlobeNewswire Inc.Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingNASDAQ:FWPForward Pharma AS
14/04/202122h40GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020NASDAQ:FWPForward Pharma AS
14/04/202122h20Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FWPForward Pharma AS
12/01/202122h30GlobeNewswire Inc.Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 RestrictionsNASDAQ:FWPForward Pharma AS
11/09/202022h31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FWPForward Pharma AS
12/05/202023h00GlobeNewswire Inc.Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19NASDAQ:FWPForward Pharma AS
24/04/202022h50GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019NASDAQ:FWPForward Pharma AS
14/02/202022h27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FWPForward Pharma AS
26/11/201922h05GlobeNewswire Inc.Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary SharesNASDAQ:FWPForward Pharma AS
05/09/201914h30GlobeNewswire Inc.Forward Pharma to Participate in the Fall Investor Summit in New YorkNASDAQ:FWPForward Pharma AS
26/06/201922h30GlobeNewswire Inc.Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock ExchangeNASDAQ:FWPForward Pharma AS
04/04/201922h30GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018NASDAQ:FWPForward Pharma AS
27/03/201913h30GlobeNewswire Inc.Forward Pharma to Participate in the DKBIO2019 Life Science Investor ConferenceNASDAQ:FWPForward Pharma AS
24/10/201816h42GlobeNewswire Inc.Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent InterferenceNASDAQ:FWPForward Pharma AS
28/09/201813h30GlobeNewswire Inc.Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare ConferenceNASDAQ:FWPForward Pharma AS
19/09/201822h20GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018NASDAQ:FWPForward Pharma AS
23/08/201814h00GlobeNewswire Inc.Forward Pharma to Participate in the LSX Nordic CongressNASDAQ:FWPForward Pharma AS
07/05/201822h30GlobeNewswire Inc.Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 PatentNASDAQ:FWPForward Pharma AS
02/05/201815h06GlobeNewswire Inc.Forward Pharma Reports Full-Year 2017 Financial and Operational ResultsNASDAQ:FWPForward Pharma AS
07/02/201813h30GlobeNewswire Inc.Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare ConferenceNASDAQ:FWPForward Pharma AS
29/01/201816h44GlobeNewswire Inc.Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 PatentNASDAQ:FWPForward Pharma AS
 Showing the most relevant articles for your search:NASDAQ:FWP